[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Volitionrx Ltd 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 USA

www.volition.com Employees: 75 P: 512-774-8930

Sector:

Medical

Description:

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types. The Company's development activities are primarily centered in Belgium. Volition RX Ltd is based in Singapore.

Key Statistics

Overview:

Market Capitalization, $K 16,580
Enterprise Value, $K 24,590
Shares Outstanding, K 8,088
Float, K 7,384
% Float 91.30%
Short Interest, K 7,088
Short Float 87.61%
Days to Cover 1.68
Short Volume Ratio 0.64
% of Insider Shareholders 8.70%
% of Institutional Shareholders 8.09%

Financials:

Annual Sales, $ 1,730 K
Annual Net Income, $ -23,360 K
Last Quarter Sales, $ 450 K
Last Quarter Net Income, $ -6,270 K
EBIT, $ -21,740 K
EBITDA, $ -18,800 K

Growth:

1-Year Return -76.56%
3-Year Return -92.47%
5-Year Return -96.67%
5-Year Revenue Growth 17,200.00%
5-Year Earnings Growth 51.11%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.00 on 03/31/26
Next Earnings Date 05/21/26 [AMC]
Earnings Per Share ttm -4.20
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year 16.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 04/28/26

VNRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -291.77%
Profit Margin % -1,350.29%
Debt/Equity -0.26
Price/Sales 10.54
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -5.30
Interest Coverage -43.34
60-Month Beta 1.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.